Reimbursement/Billing. ENDRA agrees that the Equipment will not be used on human subjects for any clinical diagnostic purposes. Accordingly, ENDRA agrees that it will not submit any claims to any patient, government healthcare program or third party payor involving the use of the Equipment.
Reimbursement/Billing. (a) The Products are covered when ordered by an eligible provider and when medically necessary for a specific patient who is eligible for coverage and meets the criteria of the applicable coverage policy for: (a) Medicare (Title XVIII of the Social Security Act ("Medicare")) in the amounts set forth in the Disclosure Schedule, such amount being subject to periodic change, except for the states listed on Disclosure Schedule; (b) all state Medicaid programs (Title XIX of the Social Security Act ("Medicaid")), except for the states listed on the Disclosure Schedule; and (c) those private third party payors ("Third Party Payors") listed on the Disclosure Schedule. The Company is neither a provider nor a supplier under Medicare, Medicaid or any other government-sponsored health care program, not including Veterans Administration Hospitals and Clinics (collectively, "Government Programs"), and does not bill any Government Program ox Xxird Party Payor for its products. The Company does not participate, and has never participated, in any Government Programs, and it does not bill, and has never billed, anx Xovernment Program, directly or indirectly.
Reimbursement/Billing. The Company has not sold any Products, has not sought reimbursement for any Product and has not made any billing applicable to the Product.
Reimbursement/Billing. (a) The Company's products have not yet received final approval by the FDA and thus reimbursement for the products and related services are subject to various limitations by federal and other payors. The Company's 3F Aortic Bioprosthesis(TM) was recognized as a Category B2 device by FDA and thus was eligible for Medicare coverage during and under the investigational device exemption. Medicare (Title XVIII of the Social Security Act ("Medicare")), covers heart valve procedures and pays the hospital for the costs of the inpatient services under a prospective payment system, utilizing diagnosis related groups (DRGs). Applicable DRGs include DRGs 104 and 105 for cardiac valve procedures which pay hospitals in the range of $38,000 and $28,000 respectively for the procedures during 2006. Coverage and payment under state Medicaid programs (Title XIX of the Social Security Act ("Medicaid")) and private third party payors ("Third Party Payors") are similarly subject to various limitations and coverage and payment will vary widely by payor. The Company provided hospital investigational sites with basic reimbursement information in 2003 (a copy of a May 27, 2003 reimbursement letter has been provided to Parent). The Company is neither a provider nor a supplier under Medicare, Medicaid or any other government-sponsored health care program (collectively, "Government Programs"), and does not bill any Government Program or Third Party Payor for its prxxxxts.
Reimbursement/Billing. (a) Parent's products are covered by: (a) Medicare, under a national coverage decision providing for payment for its products in the amounts disclosed to the Company; (b) Medicaid; and (c) Third Party Payors. Any Third Party Payor that has been requested to approve Parent's products for reimbursement and has declined to do so has been disclosed to the Company. Parent is neither a provider nor a supplier under any Government Program, and does not bill any Government Program or Third Party Payor for its prxxxxts.
Reimbursement/Billing. To its knowledge, the Company has not engaged in any activities that are prohibited, or are cause for civil or criminal penalties or mandatory or permissive exclusion from Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security Act) or any other State Health Care Program or Federal Health Care Program (each, a “Program”) under 42 U.S.C. §§ 1320a-7, 1320a-7a, 1320a-7b, or §1395nn, or the Federal False Claims Act, 31 USC § 3729, or the regulations promulgated pursuant to such statutes. To the knowledge of the Company, there is no civil, criminal, administrative or other action, suit, demand, claim, hearing, investigation, proceeding, notice or demand threatened against the Company, that could reasonably be expected to result in its exclusion from participation in any Program or other third party payment programs in which the Company participates. The Company has not been sanctioned within the meaning of Social Security Act Section 1128A or any amendments thereof or debarred, excluded or suspended from participation in any federal or state health care program. In addition, neither the Company nor any of its directors or officers have been debarred or convicted of a crime for which a person or entity can be debarred under 21 U.S.C. § 335a, nor to the knowledge of the Company has the company or any of its directors or officers been threatened to be debarred or indicted for a crime or otherwise engaged in conduct for which a person or entity can be debarred.
Reimbursement/Billing. In connection with the Business:
Reimbursement/Billing. (a) The Company's products identified on Schedule 3.7(a) attached to this Agreement may be reimbursed by Medicare (Title XVIII of the Social Security Act ("Medicare"). Notwithstanding the foregoing, the Company represents that it does not participate, and it has never participated in, Medicare, Medicaid or any other government-sponsored health care program (collectively, "Government Programs"), and it does not xxxx, and it has never billed, any Government Program for the Products, directly or indirectly.
Reimbursement/Billing. As Seller has not sold any products in the Urology Business, there are no issues relating to reimbursement or billing applicable to the Urology Business.
Reimbursement/Billing. (a) The Company is neither a provider nor a supplier under Medicare, Medicaid or any other government-sponsored health care program (collectively, “Government Programs”), and does not bxxx any Government Program or third party payor for its products.
